Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.38 USD | +5.04% |
|
+31.01% | -5.25% |
Business Summary
Number of employees: 140
Managers
Managers | Title | Age | Since |
---|---|---|---|
Barbara Weber
CEO | Chief Executive Officer | 67 | 01/17/01 |
Daniella Beckman
DFI | Director of Finance/CFO | 45 | 01/16/01 |
Jannik Andersen
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Adam Crystal
CTO | Chief Tech/Sci/R&D Officer | 47 | 27/23/27 |
Compliance Officer | 54 | 01/21/01 | |
Samy Tadros
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alexis Borisy
CHM | Chairman | 52 | 01/17/01 |
Mace Rothenberg
BRD | Director/Board Member | 67 | 01/21/01 |
Barbara Weber
CEO | Chief Executive Officer | 67 | 01/17/01 |
Lesley Calhoun
BRD | Director/Board Member | 58 | 01/21/01 |
Malte Peters
BRD | Director/Board Member | 61 | 01/18/01 |
John Ketchum
BRD | Director/Board Member | 68 | 29/23/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 106,846,262 | 92,722,493 ( 86.78 %) | 0 | 86.78 % |
Company contact information
![address Tango Therapeutics, Inc.(TNGX)](https://cdn.zonebourse.com/static/address/111641934.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.25% | 100.22Cr | |
+38.66% | 5.28TCr | |
-7.81% | 3.89TCr | |
+35.51% | 3.82TCr | |
-10.77% | 2.68TCr | |
+11.77% | 2.62TCr | |
-17.82% | 1.99TCr | |
+35.09% | 1.32TCr | |
+29.17% | 1.22TCr | |
-3.05% | 1.18TCr |
- Stock Market
- Equities
- TNGX Stock
- Company Tango Therapeutics, Inc.